Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for patient and data collection in clinical trials, today announced the completion of a €3.6M growth financing round.
Kayentis’ experience of over 120 clinical trials 75 countries (6,000 sites and 50,000 patients), and in a broad range of therapeutic areas, has shown its added value to data quality and clinical trial efficiency with innovative and intuitive solutions, and two development priorities: Patient Engagement and Risk-based Monitoring.
The funds raised will enable Kayentis to accelerate its growth internationally and to position itself as a leading global provider of eCOA solutions.